Literature DB >> 11556806

Antiplasmodial activity of nitroaromatic and quinoidal compounds: redox potential vs. inhibition of erythrocyte glutathione reductase.

P Grellier1, J Sarlauskas, Z Anusevicius, A Maroziene, C Houee-Levin, J Schrevel, N Cenas.   

Abstract

Prooxidant nitroaromatic and quinoidal compounds possess antimalarial activity, which might be attributed either to their formation of reactive oxygen species or to their inhibition of antioxidant enzyme glutathione reductase (GR, EC 1.6.4.2). We have examined the activity in vitro against Plasmodium falciparum of 24 prooxidant compounds of different structure (nitrobenzenes, nitrofurans, quinones, 1,1'-dibenzyl-4,4'-bipyridinium, and methylene blue), which possess a broad range of single-electron reduction potentials (E(1)(7)) and erythrocyte glutathione reductase inhibition constants (K(i(GR))). For a series of homologous derivatives of 2-(5'-nitrofurylvinyl)quinoline-4-carbonic acid, the relationship between compound K(i(GR)) and concentration causing 50% parasite growth inhibition (IC(50)) was absent. For all the compounds examined in this study, the dependence of IC(50) on their K(i(GR)) was insignificant. In contrast, IC(50) decreased with an increase in E(1)(7) and positive electrostatic charge of aromatic part of molecule (Z): log IC(50) (microM) = -(0.9846 +/- 0.3525) - (7.2850 +/- 1.2340) E(1)(7) (V) - (1.1034 +/- 0.1832) Z (r(2) = 0.8015). The redox cycling activity of nitroaromatic and quinoidal compounds in ferredoxin:NADP(+) reductase-catalyzed reaction and the rate of oxyhemoglobin oxidation in lysed erythrocytes increased with an increase in their E(1)(7) value. Our findings imply that the antiplasmodial activity of nitroaromatic and quinoidal compounds is mainly influenced by their ability to form reactive oxygen species, and much less significantly by the GR inhibition. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556806     DOI: 10.1006/abbi.2001.2487

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.

Authors:  Svenja Meierjohann; Rolf D Walter; Sylke Müller
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

2.  Glutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquito.

Authors:  Rebecca Pastrana-Mena; Rhoel R Dinglasan; Blandine Franke-Fayard; Joel Vega-Rodríguez; Mariela Fuentes-Caraballo; Abel Baerga-Ortiz; Isabelle Coppens; Marcelo Jacobs-Lorena; Chris J Janse; Adelfa E Serrano
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

3.  Catechin Isolated from Garcinia celebica Leaves Inhibit Plasmodium falciparum Growth through the Induction of Oxidative Stress.

Authors:  Rizky Abdulah; Eka W Suradji; Anas Subarnas; Unang Supratman; Milyadi Sugijanto; Ajeng Diantini; Keri Lestari; Melisa I Barliana; Shinichiro Kawazu; Hiroshi Koyama
Journal:  Pharmacogn Mag       Date:  2017-07-11       Impact factor: 1.085

4.  Reactions of Plasmodium falciparum Ferredoxin:NADP+ Oxidoreductase with Redox Cycling Xenobiotics: A Mechanistic Study.

Authors:  Mindaugas Lesanavičius; Alessandro Aliverti; Jonas Šarlauskas; Narimantas Čėnas
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

5.  Determination of the inhibitory effects of N-methylpyrrole derivatives on glutathione reductase enzyme.

Authors:  Esma Kocaoğlu; Oktay Talaz; Hüseyin Çavdar; Murat Şentürk; Claudiu T Supuran; Deniz Ekinci
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on Plasmodium falciparum Glutathione Reductase.

Authors:  Audronė Marozienė; Mindaugas Lesanavičius; Elisabeth Davioud-Charvet; Alessandro Aliverti; Philippe Grellier; Jonas Šarlauskas; Narimantas Čėnas
Journal:  Molecules       Date:  2019-12-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.